Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2009

01-02-2009 | Original Article

Factors Associated with First-Fill Adherence Rates for Diabetic Medications: A Cohort Study

Authors: Nirav R. Shah, MD, MPH, Annemarie G. Hirsch, MPH, Christopher Zacker, RPh, PhD, Scott Taylor, RPh, MBA, G. Craig Wood, MS, Walter F. Stewart, PhD, MPH

Published in: Journal of General Internal Medicine | Issue 2/2009

Login to get access

Abstract

Background

Little is known about first-fill adherence rates for diabetic medications and factors associated with non-fill.

Objective

To assess the proportion of patients who fill their initial prescription for a diabetes medication, understand characteristics associated with prescription first-fill rates, and examine the effect of first-fill rates on subsequent A1c levels.

Design

Retrospective, cohort study linking electronic health records and pharmacy claims.

Participants

One thousand one hundred thirty-two patients over the age of 18 who sought care from the Geisinger Clinic, had Geisinger Health Plan pharmacy benefits, and were prescribed a diabetes medication for the first time between 2002 and 2006.

Measurements

The primary outcome of interest was naïve prescription filled by the patient within 30 days of the prescription order date.

Results

The overall first-fill adherence rate for antidiabetic drugs was 85%. Copays < $10 (OR 2.22, 95% CI 1.57–3.14) and baseline A1c > 9% (OR 2.63, 95% CI 1.35, 5.09) were associated with improved first-fill rates while sex, age, and co-morbidity score had no association. A1c levels decreased among both filling and non-filling patients though significantly greater reductions were observed among filling patients. Biguanides and sulfonylureas had higher first-fill rates than second-line oral agents or insulin.

Conclusions

First-fill rates for diabetes medication have room for improvement. Several factors that predict non-filling are readily identifiable and should be considered as possible targets for interventions.
Literature
1.
go back to reference Haynes TB, Taylor DW, Sackett DL. Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press; 1979. Haynes TB, Taylor DW, Sackett DL. Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press; 1979.
2.
go back to reference Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care. 2005;43(6):517–20.CrossRefPubMed Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care. 2005;43(6):517–20.CrossRefPubMed
3.
go back to reference Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood). 2003;22(4)220–9.CrossRef Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood). 2003;22(4)220–9.CrossRef
4.
go back to reference McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288(22):2868–79.CrossRefPubMed McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288(22):2868–79.CrossRefPubMed
5.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5)373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5)373–83.CrossRefPubMed
6.
go back to reference Rothman KJ, Greenland S. Modern Epidemiology, 2nd edn. New York: Lippincott Williams & Wilkins; 1998. Rothman KJ, Greenland S. Modern Epidemiology, 2nd edn. New York: Lippincott Williams & Wilkins; 1998.
7.
go back to reference Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diab Care. 2004;27(12):2800–5.CrossRef Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diab Care. 2004;27(12):2800–5.CrossRef
8.
go back to reference Schetman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diab Care. 2002;25(6):1015–21.CrossRef Schetman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diab Care. 2002;25(6):1015–21.CrossRef
9.
go back to reference Kienle GS, Kiene H. The powerful placebo effect: Fact or fiction? J Clin Epi. 1997;50(12):1311–8.CrossRef Kienle GS, Kiene H. The powerful placebo effect: Fact or fiction? J Clin Epi. 1997;50(12):1311–8.CrossRef
10.
go back to reference Johnson RE, Goodman MJ, Hornbrook MC, Eldredge MB. The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members. Med Care. 1997;35:1119–31.CrossRefPubMed Johnson RE, Goodman MJ, Hornbrook MC, Eldredge MB. The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members. Med Care. 1997;35:1119–31.CrossRefPubMed
11.
go back to reference Babazono A, Tsuda T, Yamamoto E, Mino Y, Une H, Hillman AL. Effects of an increase in patient copayments on medical service demands of the insured in Japan. Int J Technol Assess Health Care. 2003;19(3):465–75.CrossRefPubMed Babazono A, Tsuda T, Yamamoto E, Mino Y, Une H, Hillman AL. Effects of an increase in patient copayments on medical service demands of the insured in Japan. Int J Technol Assess Health Care. 2003;19(3):465–75.CrossRefPubMed
12.
go back to reference Chernew M, Gibson TB, Yu-Isenberg K, Sokol MC, Rosen AB, Fendrick AM. Effects of increased patient cost sharing on socioeconomic disparities in health care. J Gen Int Med 2008;epub ahead of print. Chernew M, Gibson TB, Yu-Isenberg K, Sokol MC, Rosen AB, Fendrick AM. Effects of increased patient cost sharing on socioeconomic disparities in health care. J Gen Int Med 2008;epub ahead of print.
13.
go back to reference DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–9.CrossRefPubMed DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–9.CrossRefPubMed
14.
go back to reference van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: A review of reviews. BMC Health Services Research. 2007;7(55). van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: A review of reviews. BMC Health Services Research. 2007;7(55).
15.
go back to reference Ho PM, Magid DJ, Shetterly SM, et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med. 2008;168(3):271–6.CrossRefPubMed Ho PM, Magid DJ, Shetterly SM, et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med. 2008;168(3):271–6.CrossRefPubMed
16.
go back to reference Schmittdiel JA, Uratsu CS, Karter AJ, et al. Why don’t diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008;23(5):588–94.CrossRefPubMed Schmittdiel JA, Uratsu CS, Karter AJ, et al. Why don’t diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008;23(5):588–94.CrossRefPubMed
Metadata
Title
Factors Associated with First-Fill Adherence Rates for Diabetic Medications: A Cohort Study
Authors
Nirav R. Shah, MD, MPH
Annemarie G. Hirsch, MPH
Christopher Zacker, RPh, PhD
Scott Taylor, RPh, MBA
G. Craig Wood, MS
Walter F. Stewart, PhD, MPH
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 2/2009
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-008-0870-z

Other articles of this Issue 2/2009

Journal of General Internal Medicine 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine